In recognition of National Infertility Awareness Week, April 21-27, PCCA Director of Clinical Services Sara Hover, RPh, FAARM, discusses how fertility is increasingly viewed as an indicator of overall health; how the intertwine of metabolic balance, hormone production and mitochondria impact fertility; as well as a way compounders can help those whose individual needs exceed commercially available medicines.

Compounding pharmacists are committed to helping their patients live healthier, better lives —and key to this is ensuring their patients have continuing access to lawfully prescribed, personalized medications tailored to their individual needs.

The human body is a complex network of interconnected systems, and recent research has shed light on the intricate relationship between visceral adipose tissue (VAT), estradiol levels and cognitive health.

Genitourinary syndrome of menopause (GSM), also known as vulvovaginal atrophy, is common among menopausal women. Learn more about GSM, relevant hormones and the importance of choosing the right base for compounding preparations.

Sara Hover of PCCA's Clinical Services discusses medical treatment and management options for pharmacists helping patients whose health is challenged by polycystic ovary syndrome (PCOS).

In the first part of this article, Pamela, Nat, and Sara shined a light on new health risk information compounders should consider when providing bioidentical hormone replacement therapy. In this second part of the article, they dive deeper into the BHRT conversation, discussing compounded topical estrogen as an option.

Compounded bioidentical hormone replacement therapy (BHRT) is an important treatment option for women around the world. Colleagues and patients alike come to PCCA experts Pamela Smith, Nat Jones and Sara Hover for guidance. In this article, our three experts cover this all-too-important topic in the HRT conversation, on what current literature says about the usage of oral vs. topical estrogen discussion.

PCCA launches an exciting new base at their 2019 International Seminar. Click here to learn all about it.

Compounders who use progesterone in their formulations are faced with the question, "Should I used micronized or wettable progesterone?" With the help of PCCA's Clinical Services team, we're here to help guide you through making the best decision in specific situations.

Compounding pharmacies have been using PCCA's VersaBase Cream for years. Today, we'd like to talk to you about VersaBase's incredible ability to assist in women's Hormone Replacement Therapy.